In consequence, based on existing case-control studies, we carried out this new meta-analysis, aiming to elucidate the correlation between ERCC1 rs11615 polymorphism and cervical cancer susceptibility and better predict the occurrence and development of cervical cancer in clinical practice. This evidence concerns the gene ERCC1 and cervical carcinoma.